Book on Doctolib
← Back to articles
Retinal Diseases Written and reviewed by Dr Julien Gozlan, ophthalmic surgeon · 03/09/2026 Updated 08/09/2026
Fundus imaging of congenital hypertrophy of the retinal pigment epithelium — Dr Julien Gozlan

Congenital hypertrophy of the retinal pigment epithelium

Dr Julien Gozlan
Dr Julien Gozlan
Ophthalmic Surgeon · Cataract & Retina Specialist · Paris 16

Congenital hypertrophy of the retinal pigment epithelium is a benign and very common lesion of the fundus, present from birth. It appears as a flat, well-defined and heavily pigmented spot, most often discovered by chance. Benign and silent, it mainly needs to be recognised so as not to be confused with a tumour. Dr Julien Gozlan, ophthalmic surgeon specialising in the retina in Paris 16, explains what congenital hypertrophy of the retinal pigment epithelium is, how it is diagnosed and in which cases it warrants further investigation.

What is congenital hypertrophy of the retinal pigment epithelium?

Congenital hypertrophy of the retinal pigment epithelium corresponds to a localised thickening of the retinal pigment epithelium, the thin layer of pigmented cells located beneath the retina. The cells there are larger and more loaded with pigment than normal, which gives the lesion its characteristic dark colour.

It is an abnormality present from birth, of an entirely benign nature. Congenital hypertrophy of the retinal pigment epithelium is not a cancer, virtually never transforms and causes, in the vast majority of cases, no visual disturbance.

What does this fundus lesion look like?

Congenital hypertrophy of the retinal pigment epithelium appears as a flat, round or oval spot, grey-black in colour, with sharp edges. Several features characterise it:

These characteristics help distinguish a congenital hypertrophy of the retinal pigment epithelium from a naevus or a tumour of the choroid.

The different forms

Several presentations of congenital hypertrophy of the retinal pigment epithelium are distinguished:

What are the symptoms?

In almost all cases, congenital hypertrophy of the retinal pigment epithelium is asymptomatic. The patient feels no discomfort, and the lesion does not affect vision. It is almost always discovered incidentally during a fundus examination carried out for another reason.

Rarely, when it is extensive and affects the centre of the retina, it can be responsible for a small visual field defect (scotoma) corresponding to the pigmented area, without loss of central visual acuity.

How is this lesion diagnosed?

The diagnosis of congenital hypertrophy of the retinal pigment epithelium is based on the fundus examination and imaging performed at Dr Julien Gozlan's practice:

These examinations confirm the benign nature of the lesion and rule out a tumour.

Congenital hypertrophy of the retinal pigment epithelium or a pigmented tumour?

The main value of the diagnosis is to differentiate this lesion from a true pigmented tumour:

The flat, stable and well-defined nature of the lesion is reassuring and strongly points to the diagnosis.

Multifocal form: investigation sometimes needed

The vast majority of congenital hypertrophies of the retinal pigment epithelium, whether solitary or grouped, are associated with no systemic disease and do not increase the risk of cancer.

By contrast, a particular form, made of multiple small "comet-tail" pigmented lesions distributed over both eyes, can be associated with familial digestive polyposis (familial adenomatous polyposis, Gardner syndrome). In this specific case, a digestive work-up and a specialist opinion are recommended. This is why the discovery of bilateral multifocal lesions always deserves careful analysis.

Does it need treatment and monitoring?

Congenital hypertrophy of the retinal pigment epithelium requires no treatment. Management relies on simple monitoring:

FAQ: congenital hypertrophy of the retinal pigment epithelium

Is congenital hypertrophy of the retinal pigment epithelium dangerous?

No. It is a benign lesion, present since birth, which does not affect vision and virtually never transforms. It simply needs to be recognised and differentiated from a tumour.

Can it turn into a melanoma?

Progression to a malignant tumour is exceptional. Unlike melanoma, congenital hypertrophy of the retinal pigment epithelium remains flat and stable. Spaced-out photographic monitoring is enough to confirm this stability.

Is this lesion linked to colon cancer?

The solitary and grouped forms are not associated with colon cancer. Only the bilateral multifocal form can be a marker of familial digestive polyposis and then warrants an appropriate work-up.

Is treatment needed?

No, no treatment is necessary. Congenital hypertrophy of the retinal pigment epithelium calls for simple monitoring with fundus photography and OCT.

Should my relatives be examined?

For a solitary or grouped form, no family screening is necessary. In the case of a multifocal form suggesting polyposis, a digestive opinion and examination of relatives may be proposed.

When to consult Dr Julien Gozlan?

The discovery of a pigmented spot in the fundus warrants a specialist opinion to determine its nature. Dr Julien Gozlan, retina specialist in Paris 16, has the imaging (fundus photography, OCT, autofluorescence) needed to confirm congenital hypertrophy of the retinal pigment epithelium, distinguish it from a naevus or a melanoma and arrange, if needed, further investigation.

📍 Consultation at the Paris – Auteuil Ophthalmology Practice

Dr Julien Gozlan sees you at the Paris – Auteuil Ophthalmology Practice for the diagnosis and monitoring of congenital hypertrophy of the retinal pigment epithelium. Thanks to a complete retinal imaging platform (fundus photography, OCT, autofluorescence), he precisely characterises your lesion and reassures you.

Book an appointment on Doctolib

Further reading

References & medical sources

  1. Traboulsi EI, Krush AJ, Gardner EJ, et al. Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med. 1987. doi:10.1056/NEJM198703123161104 — View on PubMed
  2. Bonnet LA, Conway RM, Lim LA. Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations. Clin Ophthalmol. 2022. doi:10.2147/OPTH.S354761 — View on PubMed
  3. Shields JA, Shields CL, Shah PG, et al. Lack of association among typical congenital hypertrophy of the retinal pigment epithelium, adenomatous polyposis, and Gardner syndrome. Ophthalmology. 1992. doi:10.1016/s0161-6420(92)31736-1 — View on PubMed
  4. Shields CL, Mashayekhi A, Ho T, et al. Solitary congenital hypertrophy of the retinal pigment epithelium: clinical features and frequency of enlargement in 330 patients. Ophthalmology. 2003. doi:10.1016/S0161-6420(03)00618-3 — View on PubMed
  5. Fung AT, Pellegrini M, Shields CL. Congenital hypertrophy of the retinal pigment epithelium: enhanced-depth imaging optical coherence tomography in 18 cases. Ophthalmology. 2014. doi:10.1016/j.ophtha.2013.08.016 — View on PubMed
  6. Shields JA, Eagle RC, Shields CL, et al. Malignant transformation of congenital hypertrophy of the retinal pigment epithelium. Ophthalmology. 2009. doi:10.1016/j.ophtha.2009.04.048 — View on PubMed
Dr Julien Gozlan
Ophthalmologist
Hello, connecting you to Dr Julien Gozlan.